Enfusion, Inc. (NYSE:ENFN) Q1 2023 Earnings Conference Call May 9, 2023 8:30 AM ET

Company Participants

Ignatius Njoku - Head, IR

Oleg Movchan - CEO

Brad Herring - CFO

Conference Call Participants

Dylan Becker - William Blair

James Faucette - Morgan Stanley

J. Parker Lane - Stifel Nicolaus

Koji Ikeda - Bank of America

Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion's First Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

I'd now like to turn the call over to Ignatius Njoku, Head of Investor Relations, to begin.

Ignatius Njoku

Good morning, and thank you, Operator. We welcome you to Enfusion's first quarter 2023 earnings conference call. Hosting today's call are Oleg Movchan, Enfusion's Chief Executive Officer, and Brad Herring, Enfusion's Chief Financial Officer.

Please note, our quarterly shareholder letter, which includes our quarterly financial results, have all been posted to our IR website. I'd like to remind you that today's call may contain forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those set forth in our filings with the SEC and are available in the Investor Relations section on our website.

Actual results may differ materially from any forward-looking statements we make today. These forward-looking statements speak only as of today, and the company does not assume any obligation or intent to update them following today's call, except as required by law.

In addition, today's call may include non-GAAP measures. These GAAP measures should be considered as a supplement to and not a substitute for GAAP financial measures. Reconciliation to the nearest GAAP measure can be found in today's quarterly shareholder letter, which is available on the company's website.

With that, I'd like to turn the call over to Oleg to begin.

Oleg Movchan

Good morning, and thank you all for joining us today to discuss our first quarter 2023 results. I'm happy to announce another strong quarter for Enfusion. Our business performed in line with our expectations for both revenue and profitability despite ongoing macroeconomic and market uncertainty.

Enfusion continues to capture hearts and minds of both new and existing clients across all investment strategies, asset classes and regions. We are focused on enhancing and protecting our unique competitive advantage centered around the best-in-class software and services offering.

This model is the strategic foundation of our ability to unlock new and adjacent market segments with an alternative investment space, increase our market share with traditional investment managers, and expand our global footprint. Despite historically extreme negative performance across all asset classes last year and ongoing macroeconomic uncertainty, our business has delivered strong outcomes this quarter.